Detalhe da pesquisa
1.
Safety and immunogenicity of the H56:IC31 tuberculosis vaccine candidate in adults successfully treated for drug-susceptible pulmonary TB: a phase 1 randomized trial.
J Infect Dis
; 2024 Apr 01.
Artigo
Inglês
| MEDLINE | ID: mdl-38557639
2.
Prevention of M. tuberculosis Infection with H4:IC31 Vaccine or BCG Revaccination.
N Engl J Med
; 379(2): 138-149, 2018 07 12.
Artigo
Inglês
| MEDLINE | ID: mdl-29996082
3.
A phase 1b randomized study of the safety and immunological responses to vaccination with H4:IC31, H56:IC31, and BCG revaccination in Mycobacterium tuberculosis-uninfected adolescents in Cape Town, South Africa.
EClinicalMedicine
; 21: 100313, 2020 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-32382714